Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Delivery of apoptotic neutrophils to improve angiogenesis during wound healing

$1.73M USD

Funder NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
Recipient Organization University of California-Irvine
Country United States
Start Date Aug 20, 2024
End Date Jul 31, 2026
Duration 710 days
Number of Grantees 2
Roles Principal Investigator; Co-Investigator
Data Source NIH (US)
Grant ID 10989559
Grant Description

PROJECT SUMMARY/ABSTRACT Every year, millions of patients suffer from impaired wound healing due to injuries, surgeries, and diseases, creating a significant public health and economic burden. The process of skin wound healing involves clotting, inflammation, cell proliferation and migration, re-vascularization, and

remodeling, and often results in scarring. In diabetic patients or large wounds, insufficient angiogenesis slows healing and worsens scarring. Attempts to deliver growth and angiogenic factors or cells fall short of providing complete relief, and there is a critical need for new strategies to promote angiogenesis and tissue repair during wound healing. The proposed project aims to

develop a novel therapeutic approach for improved angiogenesis during wound healing by leveraging natural interactions of immune cells. We propose to deliver apoptotic neutrophils (AN) within a degradable hydrogel scaffold that will induce efferocytosis and phagocytosis, respectively, in local macrophages (Mφs), promoting their angiogenic signaling and tissue repair without

causing inflammation. In preliminary work, AN delivery in a gelatin methacrylate (GelMA)-based hydrogel significantly enhanced angiogenesis in a murine skin wound model, both in wild type and in diabetic mice. Furthermore, addition of AN and/or GelMA to macrophages in culture stimulated their secretion of angiogenic growth factors. We propose here to investigate the effects

of GelMA-AN on Mφ uptake and growth factor secretion (Aim 1), and on angiogenesis and wound healing of a full-thickness skin wound (Aim 2). This project will establish a new method to enhance Mφ angiogenesis signaling, providing a platform for further investigation, and developing a therapeutic intervention for improved wound healing. This proposed approach leverages the role

of immune cells and angiogenesis in wound healing, with modulation of Mφs phenotype conversion for successful wound healing and tissue repair.

All Grantees

University of California-Irvine

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant